7.57 USD
▲+0.19+2.16%
盘后 7.27 -1.89%
2026-08-03
市值
$390.58M
市盈率
—
EPS
-0.21
股息率
—
52 周区间
5.62 – 14.06
成交量
489.10K
Beta
2.34
目标价
12.00
52W 低 5.6252W 高 14.06
价格走势
公司简介
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma ...